RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 53 filers reported holding RECRO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $61,000 | -66.5% | 35,886 | -59.3% | 0.00% | -100.0% |
| Q3 2021 | $182,000 | -10.8% | 88,163 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $204,000 | -22.7% | 88,163 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $264,000 | -1.9% | 94,450 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $269,000 | -80.4% | 94,450 | -85.5% | 0.00% | -87.5% |
| Q3 2020 | $1,369,000 | -30.7% | 652,036 | +50.2% | 0.01% | -38.5% |
| Q2 2020 | $1,975,000 | +11.0% | 434,061 | +148.0% | 0.01% | 0.0% |
| Q2 2019 | $1,780,000 | – | 175,055 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |